Table 2.
RE-AIM Evaluation of Perinatal Addiction Education
| Dimension and questions addressed | Data sources | Methods | Outcome/Process measures |
|---|---|---|---|
| Reach | |||
| To what extent did perinatal addiction education reach the providers treating pregnant women with OUD in Your Counties? | Department of Professional Licensing | Identify all healthcare providers in the community licensed to potentially treat pregnant women with OUD | Number of community providers included in the study/ total number of community providers working with pregnant women with OUD |
| To what extent did perinatal addiction education reach the pregnant women with OUD within the healthcare system in Your Counties? | Local healthcare and social service agencies | Electronic medical records; health department records | Number of patient participants/ total number of pregnant women with opioid misuse in Your Counties during the study duration |
| Efficacy | |||
| How effective was the provider training and support? | Community providers | Questionnaires assessing skills, knowledge and satisfaction | Mixed method surveys regarding provider experience and skillset |
| How effective were perinatal addiction education services in improving care for pregnant women with OUD? | Healthcare and social service records; patient participants | Compare data regarding illicit substance use, MOUD continuity, opioid poisoning occurrences, physical and mental health, and social service involvement; questionnaires to assess patient perception | Medical codes; standardized comprehensive wellness measurement instruments; qualitative surveys |
| Adoption | |||
| To what extent are community providers using perinatal addiction education practices when treating patients with perinatal OUD? | Community providers; local healthcare agencies | Questionnaires assessing provider practices and attitudes; electronic medical records | Mixed methods surveys regarding provider practices; frequency of MOUD provision, NOWS treatment and SBIRT by participating community providers |
| To what extent are patients utilizing resources made available through the perinatal addiction education program? | Partnering agencies (e.g. EUWH, Four Corners Behavioral Health); medical records; pharmacy records | Interviews with partner agencies; electronic medical record and pharmacy record evaluation | Utilization of care management and resources made available through this project; number of MOUD prescriptions filled; presence of BUP in urinalysis via medical record |
| Implementation | |||
| What were the barriers and facilitators of high quality care? | Community providers | Questionnaires and focus groups | Perceptions of and feedback regarding the implementation kickoff event, as well as ongoing training and support provided via the implementation of perinatal addiction education |
| Maintenance | |||
| Will the perinatal addiction education practices be maintained over time in Your Counties? | Community providers; healthcare administrators | Interviews and questionnaires with community providers and healthcare administrators regarding provider practices and policies | Questionnaire regarding how integrated perinatal addiction education practices are into standard treatment of pregnant women with OUD and what policies exist to support them |
OUD Opioid Use Disorder, MOUD Medication for Opioid Use Disorder, NOWS Neonatal Opioid Withdrawal Syndrome, SBIRT Screening, Brief Intervention, and Referral to Treatment; BUP Buprenorphine